Clinical Study

Efficacy and Safety of Halometasone Cream to Treat Chronic Generalized Eczema and the Effects of Halometasone Cream on Serum Cortisol Levels

Table 1

Baseline characteristics.

Total
Group A
Group B
Group C
value

Age (year)
 Range (Min, Max)22–7823–7832–7422–78
 Mean ± SD54.7 ± 16.154.8 ± 14.855.0 ± 14.054.1 ± 21.00.985

Sex
 Men, (%)37 (61.7)15 (53.6)15 (88.2)7 (46.7)
 Women, (%)23 (38.3)13 (46.4)2 (11.8)8 (53.3)

Lesion area (%)30–6030–4041–5051–60
Disease history (month)
 Range (Min, Max)2–2403–2406–1202–240
 Mean ± SD61.5 ± 57.655.8 ± 46.553.8 ± 33.780.7 ± 89.40.332

Lesion status
 EASI, Mean ± SD30.7 ± 8.723.9 ± 4.234.0 ± 7.5239.8 ± 4.91<0.000
Serum COR, Mean ± SD (µg/dL)10.9 ± 3.111.1 ± 4.310.9 ± 2.710.7 ± 2.00.967

SD: Standard deviation. EASI: eczema area and severity index. COR: Cortisol. One-way ANOVA was performed to compare the three groups. was considered significant different. 1Significantly higher versus group B () and group A (). 2Significantly higher versus group A ().